Small-Molecule Gankyrin Inhibition as a Therapeutic Strategy for Breast and Lung Cancer.


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
14 07 2022
Historique:
pubmed: 28 6 2022
medline: 16 7 2022
entrez: 27 6 2022
Statut: ppublish

Résumé

Gankyrin is an oncoprotein responsible for the development of numerous cancer types. It regulates the expression levels of multiple tumor suppressor proteins (TSPs) in liver cancer; however, gankyrin's regulation of these TSPs in breast and lung cancers has not been thoroughly investigated. Additionally, no small-molecule gankyrin inhibitor has been developed which demonstrates potent anti-proliferative activity against gankyrin overexpressing breast and lung cancers. Herein, we are reporting the structure-based design of gankyrin-binding small molecules which potently inhibited the proliferation of gankyrin overexpressing A549 and MDA-MB-231 cancer cells, reduced colony formation, and inhibited the growth of 3D spheroids in an

Identifiants

pubmed: 35758870
doi: 10.1021/acs.jmedchem.2c00190
pmc: PMC9524259
mid: NIHMS1835462
doi:

Substances chimiques

Tumor Suppressor Proteins 0
Proteasome Endopeptidase Complex EC 3.4.25.1

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

8975-8997

Subventions

Organisme : NIGMS NIH HHS
ID : R15 GM126432
Pays : United States
Organisme : NIGMS NIH HHS
ID : SC2 GM139672
Pays : United States

Références

Front Oncol. 2017 Dec 11;7:293
pubmed: 29322028
Front Pharmacol. 2021 Mar 04;12:580722
pubmed: 33746747
Oncogene. 2006 Aug 28;25(38):5220-7
pubmed: 16936740
Proc Natl Acad Sci U S A. 2013 May 14;110(20):E1839-48
pubmed: 23589839
J Clin Invest. 2010 Aug;120(8):2829-41
pubmed: 20628200
Cancer Cell. 2005 Jul;8(1):75-87
pubmed: 16023600
Gene. 1998 Aug 17;216(1):113-22
pubmed: 9714768
Chem Rev. 2016 Dec 14;116(23):14726-14768
pubmed: 27960271
Biochem Biophys Res Commun. 2017 Aug 26;490(3):1052-1058
pubmed: 28668389
Cell. 2009 May 15;137(4):609-22
pubmed: 19450511
Trends Cell Biol. 2006 May;16(5):229-33
pubmed: 16581249
Mol Med Rep. 2014 Mar;9(3):1032-6
pubmed: 24337075
Nat Med. 2000 Jan;6(1):96-9
pubmed: 10613832
Autophagy. 2013 May;9(5):683-96
pubmed: 23419269
Hereditary Genet. 2013;2013(Suppl 2):
pubmed: 25285241
Sci Rep. 2016 Apr 05;6:23732
pubmed: 27046077
Bioorg Med Chem Lett. 2020 Sep 1;30(17):127372
pubmed: 32738965
N Engl J Med. 2017 Jun 1;376(22):2109-2121
pubmed: 28445112
Aging (Albany NY). 2009 May 07;1(5):490-502
pubmed: 20157532
Microb Cell Fact. 2005 Jul 05;4:21
pubmed: 15998469
Oncotarget. 2017 Jan 24;8(4):5909-5923
pubmed: 27992365
Bioorg Med Chem Lett. 2020 Feb 15;30(4):126889
pubmed: 31902711
Anticancer Res. 2019 Oct;39(10):5285-5296
pubmed: 31570423
Cancer Res. 1994 Apr 1;54(7):1818-24
pubmed: 8137297
Cell Cycle. 2005 Oct;4(10):1335-7
pubmed: 16177571
J Biol Chem. 2002 Mar 29;277(13):10893-902
pubmed: 11779854
J Biol Chem. 2004 Dec 17;279(51):53015-22
pubmed: 15471885
Nat Protoc. 2014 Sep;9(9):2100-22
pubmed: 25101824
Exp Mol Pathol. 2013 Apr;94(2):360-5
pubmed: 23276718
Radiat Oncol. 2012 Jan 03;7:1
pubmed: 22214341
Sci Rep. 2016 Jan 11;6:19103
pubmed: 26752500
Cancers (Basel). 2011 Mar 03;3(1):994-1013
pubmed: 24212651
Nature. 2009 Jun 11;459(7248):861-5
pubmed: 19412159
Proteins. 2014 Jul;82(7):1283-300
pubmed: 24338975
Assay Drug Dev Technol. 2014 May;12(4):207-18
pubmed: 24831787
Sci Rep. 2017 Mar 03;7:42717
pubmed: 28256516
Pathol Res Pract. 2015 Dec;211(12):939-47
pubmed: 26554593
Int J Mol Sci. 2021 Jan 09;22(2):
pubmed: 33435370
Breast Cancer Res. 2020 Jun 9;22(1):61
pubmed: 32517735
Asian Pac J Cancer Prev. 2017 Dec 29;18(12):3413-3418
pubmed: 29286612
Int J Stem Cells. 2019 Nov 30;12(3):463-473
pubmed: 31474027
Nat Protoc. 2006;1(5):2315-9
pubmed: 17406473
ACS Chem Biol. 2018 Jan 19;13(1):36-44
pubmed: 29202222
Pharmaceutics. 2019 Oct 28;11(11):
pubmed: 31661947
Oncogene. 2006 Nov 23;25(55):7305-10
pubmed: 16785993
Pharm Res. 2020 Jun 8;37(7):123
pubmed: 32514688
PLoS Med. 2010 Mar 30;7(3):e1000245
pubmed: 20361020
Ann Oncol. 1999;10 Suppl 5:S83-6
pubmed: 10582146
Biochem Soc Trans. 2006 Nov;34(Pt 5):746-8
pubmed: 17052188
Oncogene. 2013 Jul 18;32(29):3452-60
pubmed: 22890318
Cell Mol Gastroenterol Hepatol. 2018 May 24;6(3):239-255
pubmed: 30109252
Nat Protoc. 2006;1(6):2876-90
pubmed: 17406547
Radiat Oncol. 2020 Oct 29;15(1):248
pubmed: 33121517
Structure. 2003 Jan;11(1):67-73
pubmed: 12517341
Cell Death Dis. 2015 May 07;6:e1751
pubmed: 25950481
Mol Clin Oncol. 2018 Aug;9(2):115-134
pubmed: 30101008
Methods Mol Biol. 2013;962:49-61
pubmed: 23150436
J Neurosci Methods. 1997 Feb;71(2):205-13
pubmed: 9128158
Eur J Med Chem. 2019 Oct 1;179:849-862
pubmed: 31302589
Mol Cell Biol. 2000 Oct;20(20):7751-63
pubmed: 11003670
J Mol Biol. 2000 Jun 16;299(4):1121-32
pubmed: 10843863

Auteurs

Dipti Kanabar (D)

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, New York 11439, United States.

Mimansa Goyal (M)

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, New York 11439, United States.

Emma I Kane (EI)

Gustaf H. Carlson School of Chemistry & Biochemistry, Clark University, Worcester Massachusetts 01610, United States.

Tejashri Chavan (T)

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, New York 11439, United States.

Abbas Kabir (A)

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, New York 11439, United States.

Xuechun Wang (X)

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, New York 11439, United States.

Snehal Shukla (S)

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, New York 11439, United States.

Joseph Almasri (J)

Department of Chemistry, College of Liberal Arts and Sciences, St. John's University, Queens, New York 11439, United States.

Sona Goswami (S)

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, New York 11439, United States.

Gizem Osman (G)

Department of Biological Sciences, College of Liberal Arts and Sciences, St. John's University, Queens, New York 11439, United States.

Marino Kokolis (M)

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, New York 11439, United States.

Donald E Spratt (DE)

Gustaf H. Carlson School of Chemistry & Biochemistry, Clark University, Worcester Massachusetts 01610, United States.

Vivek Gupta (V)

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, New York 11439, United States.

Aaron Muth (A)

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, New York 11439, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH